Publication details

Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine

Investor logo
Authors

ŠPAČEK M. OBRTLÍKOVÁ P. HADRABOVÁ Markéta CMUNT Eduard KARBAN J. MOLINSKÝ J. SIMKOVIC M. MÓCIKOVÁ Heidi MOHAMMADOVA L. PANOVSKÁ Anna NOVÁK J. SMOLEJ Lukáš DOUBEK Michael TRNĚNÝ Marek

Year of publication 2017
Type Conference abstract
MU Faculty or unit

Faculty of Medicine

Citation
Description Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine, Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info